Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | Dec'26 | Dec'27 | Dec'28 | |
---|---|---|---|---|---|---|---|---|
Revenue growth | 126.6% | 41.0% | 45.0% | (27.9%) | 33.3% | (39.5%) | 247.9% | 180.3% |
EPS growth | 11.8% | (5.3%) | (7.1%) | 18.9% | 6.0% | 27.5% | (3.3%) | (81.8%) |
Dec'14 | Mar'15 | Jun'15 | Sep'15 | Dec'15 | Mar'16 | Jun'16 | Sep'16 | Dec'16 | Mar'17 | Jun'17 | Sep'17 | Dec'17 | Mar'18 | Jun'18 | Sep'18 | Dec'18 | Mar'19 | Jun'19 | Sep'19 | Dec'19 | Mar'20 | Jun'20 | Sep'20 | Dec'20 | Mar'21 | Jun'21 | Sep'21 | Dec'21 | Mar'22 | Jun'22 | Sep'22 | Dec'22 | Mar'23 | Jun'23 | Sep'23 | Dec'23 | Mar'24 | Jun'24 | Sep'24 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue actual | $4,000.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $385.0K | $385.0K | $8,000.0 | $8,000.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $122.0K | $122.0K | $573.0K | $573.0K | $1,988.0K | ($842.0K) | $3,144.0K | $2,701.0K | $3,156.0K | $3,414.0K | $5,722.0K | $3,643.0K | $3,371.0K | $4,765.0K | $11.4M | $9,104.0K | $2,798.0K | $2,099.0K | $12.4M | $598.0K | $1,142.0K |
Revenue estimate | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $1,609.3K | $2,375.0K | $2,375.0K | $2,375.0K | $2,375.0K | $2,375.0K | $2,375.0K | $16.5M | $2,493.8K | $3,056.2K | $2,406.2K | $7,083.0K | $5,061.2K | $9,207.3K | $4,374.3K |
Revenue surprise | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 95.4% | 13.7% | 32.9% | 43.7% | 140.9% | 53.4% | 41.9% | 71.1% | 356.1% | 197.9% | 16.3% | 70.4% | 145.1% | 93.5% | 73.9% |
EPS actual | ($0.16) | ($0.11) | ($0.11) | ($0.05) | ($0.05) | ($0.10) | ($0.10) | ($0.08) | ($0.08) | ($0.12) | ($0.12) | $0.08 | $0.08 | ($0.19) | ($0.19) | ($0.21) | ($0.21) | ($0.17) | ($0.17) | ($0.22) | ($0.22) | ($0.21) | ($0.21) | ($0.33) | ($0.07) | ($0.29) | ($0.39) | ($0.33) | ($0.32) | ($0.26) | ($0.40) | ($0.22) | ($0.43) | ($0.28) | ($0.29) | ($0.22) | ($0.37) | ($0.04) | ($0.33) | $0.00 |
EPS estimate | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ($0.58) | ($0.58) | ($0.58) | ($0.58) | ($0.58) | ($0.58) | ($0.58) | ($0.01) | ($0.12) | ($0.14) | ($0.14) | ($0.06) | ($0.10) | ($0.09) | ($0.10) |
EPS surprise | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 50.2% | 32.3% | 42.7% | 44.4% | 54.9% | 30.5% | 61.8% | 3,130.7% | 135.3% | 109.6% | 58.9% | 479.2% | 55.7% | 270.5% | 100.0% |
Silence Therapeutics plc (SLN) 1-year forward revenue growth is estimated at (27.9%).
Silence Therapeutics plc (SLN) 1-year forward EPS growth is estimated at 18.9%.
Silence Therapeutics plc (SLN) last reported EPS was $0.00, with a 100.0% beat.
Silence Therapeutics plc (SLN) had 4 beats and 6 misses in its last 10 earnings reports.